ArticleFrontiers in immunology2017

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56

Kerry Dobbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.